Browse the evidence

Combined exercise and low carbohydrate ketogenic diet interventions do not result in statistically significant changes in body mass index, body fat percentage, lean body mass, or cardiorespiratory fitness compared to control groups.

Do not be discouraged if the scale weight or BMI does not change significantly. The intervention may still be beneficial by reducing waist circumference and triglycerides, which are important for health, even if total body weight remains stable. This suggests a favorable body composition change (e.g., fat loss with muscle maintenance) that the scale does not capture.

Time-restricted eating combined with calorie restriction does not provide significant additional benefits for blood pressure, glucose profile, or lipid profile compared to calorie restriction alone.

Do not expect time-restricted eating to fix your blood pressure, blood sugar, or cholesterol if you are just counting calories. The benefits for these markers are not significantly better than just counting calories alone. Focus on the weight loss aspect of TRE.

Administration of the mitochondria-targeted protonophore C12TPP reduces body fat and weight in high-fat-diet-induced obese mice by increasing resting metabolic rate and enhancing fatty acid oxidation, independent of UCP1.

This research suggests that targeting mitochondria with specific compounds like C12TPP can reduce body fat by increasing the body's resting energy expenditure and burning more fat, even without changing food intake. This effect was most pronounced in a warm environment (thermoneutrality) and did not rely on the classic brown fat protein UCP1. While promising in mice, this is a pharmacological intervention not currently available or recommended for human weight loss.

C12TPP reduces food intake in mice, contributing to approximately one-third of the total body weight loss observed during treatment.

C12TPP treatment was associated with a significant decrease in food consumption, accounting for about 30% of the weight loss. This suggests the compound may influence appetite regulation pathways in addition to increasing metabolism.

Sulfur amino acid restriction (SAAR) induces transcriptional remodeling in white adipose tissue (WAT), upregulating ribosomal processes and downregulating structural components, without significantly altering classical metabolic risk biomarkers like lipids or glucose.

While you won't see immediate changes in your cholesterol or blood sugar, your fat tissue is biologically changing at the genetic level. Specifically, your cells are adjusting their protein synthesis machinery (ribosomes) and structural components, which may support long-term metabolic health.

A low-carbohydrate, high-fat diet may increase low-density lipoprotein cholesterol (LDLc) levels, which is a potential adverse effect compared to a control diet.

Be aware that switching to a low-carb, high-fat diet might increase your LDL cholesterol levels. However, this should be viewed in the context of improved triglycerides and HDL, which are better predictors of heart disease risk. Consult a healthcare provider if you have a history of lipid disorders.

Whey protein supplementation combined with resistance training is less effective in individuals with pathological conditions compared to healthy individuals, showing no significant improvement in lean mass, fat mass, or muscular strength.

If you have a chronic health condition, adding whey protein to your resistance training may not improve your muscle mass, fat loss, or strength. You may need to explore specialized nutritional strategies, such as multi-nutrient supplements enriched with vitamin D and leucine, which have shown benefits in some elderly or mobility-limited populations.

Rapid diet-induced weight loss in NAFLD patients is associated with decreased gut microbial diversity and specific shifts in bacterial abundance, including increased Prevotella_9 and decreased Phascolarctobacterium.

Rapid weight loss changes your gut bacteria, specifically reducing overall diversity and shifting the balance of certain species. While this is a normal response to dietary change, the long-term health implications of these specific shifts (like increased Prevotella_9) are not yet fully understood.

Bariatric surgery significantly improves glycemic control (HbA1c reduction) in patients with metabolic syndrome, with effects sustained over 5 years.

For patients with metabolic syndrome and Type 2 Diabetes, bariatric surgery offers significant and sustained improvements in blood sugar control, often superior to medical management alone.

Bariatric surgery significantly improves blood pressure and lipid profiles in patients with and without metabolic syndrome.

Bariatric surgery leads to significant and sustained improvements in blood pressure and lipid profiles, reducing cardiovascular risk.

Time-restricted eating (TRE) does not significantly change systolic or diastolic blood pressure in adults.

Do not expect TRE to lower blood pressure significantly on its own. If you have hypertension, continue standard medical management.

Modified alternate-day fasting in obese women leads to a statistically significant decrease in HDL cholesterol, which may counteract some cardiovascular benefits.

Be aware that while this fasting protocol lowers bad cholesterol and blood pressure, it may also lower 'good' (HDL) cholesterol in obese women. The net health benefit is likely positive due to larger reductions in LDL and BP, but monitoring lipid profiles is recommended.

Intermittent fasting (time-restricted feeding or alternate-day fasting) is not superior to continuous energy restriction for weight loss and may have limited long-term data.

Intermittent fasting (like time-restricted feeding) can help you lose weight, but it is not necessarily better than simply eating fewer calories every day. There is not enough long-term data to recommend it as a superior long-term strategy. Choose the method that fits your lifestyle best.

Serum HMW adiponectin levels do not significantly increase after 16 weeks of HIIT, but changes in adiponectin are strongly associated with changes in visceral adipose tissue (VAT) loss.

Don't expect HIIT to magically boost your adiponectin levels. However, if you lose visceral fat through HIIT, your adiponectin levels will likely improve as a result of that fat loss, not the exercise itself.

The effect of Tirzepatide on Fat-Free Mass (FFM) is inconclusive and potentially adverse, with some studies showing greater FFM loss compared to other anti-obesity drugs, particularly at higher doses.

While Tirzepatide is excellent for fat loss, patients should be aware that it may also cause a loss of lean muscle mass, potentially more than other similar drugs. To mitigate this, combining TZP treatment with resistance training and adequate protein intake is crucial, although clinical data on optimizing FFM preservation with TZP is currently lacking.

Specific polyphenols, such as resveratrol and quercetin, exert cardioprotective effects by inhibiting LDL oxidation, reducing platelet aggregation, and improving endothelial function.

Incorporate sources of resveratrol (grapes, red wine) and quercetin (onions, apples) into your diet to support heart health. These compounds help prevent arterial damage by reducing oxidative stress and improving blood vessel function.

Polyphenols exhibit anti-cancer properties by inducing apoptosis, inhibiting cell proliferation, and modulating detoxification enzymes, with specific efficacy observed in prostate, lung, and colorectal cancer models.

Include polyphenol-rich foods like tea, berries, and grapes in your diet as part of a cancer-preventive strategy. While not a cure, these compounds may help inhibit cancer cell growth and promote cell death in pre-cancerous states.

A lower omega-6 to omega-3 ratio (specifically 2.5:1) reduces rectal cell proliferation in patients with colorectal cancer, whereas a higher ratio (4:1) with the same omega-3 amount has no effect.

If you have colorectal cancer or are at high risk, aim for a very low omega-6 to omega-3 ratio of 2.5:1. This requires significantly reducing omega-6 oils (corn, soy, sunflower) and increasing omega-3 sources (fatty fish, flaxseed). Simply taking fish oil without reducing omega-6 may not provide the same protective benefits against cell proliferation.

Butyrate and propionate, produced by gut microbiota from dietary fiber, play a protective role against colorectal cancer (CRC) and metabolic syndrome by promoting apoptosis in cancer cells and improving insulin sensitivity.

To reduce your risk of colorectal cancer and metabolic syndrome, focus on eating a diet rich in diverse fibers (vegetables, fruits, whole grains, legumes). This feeds your gut bacteria to produce butyrate and propionate, which help protect colon cells and improve metabolic health. While supplements exist, whole food sources are preferred for overall health.

Antioxidant supplementation (e.g., 2-mercaptoethylamine, Santoquin, Selenium) increases life span and enhances immune function in animal models.

In animal studies, specific antioxidants like 2-mercaptoethylamine extended life span by 30%. While direct human translation is theoretical, incorporating antioxidant-rich foods is a plausible strategy for healthspan.

Caloric restriction (food restriction) extends life span by decreasing oxygen consumption and reducing mitochondrial free radical damage.

Maintaining a body weight that is compatible with a sense of well-being, potentially through mild caloric restriction, may reduce the rate of mitochondrial damage and extend healthy life.

Acute weight loss or fasting triggers a transient, physiological influx of macrophages into adipose tissue to clear lipid droplets from dead adipocytes, which is a healthy adaptive response distinct from chronic pathological inflammation.

When you lose weight rapidly, your body temporarily sends immune cells to clean up dead fat cells. This causes a short-term spike in inflammation markers, but it is a normal, healthy part of the process, not a sign of damage.

Routine screening for Obstructive Sleep Apnea (OSA) in PCOS is not recommended for the purpose of improving cardiometabolic risk, as there is inadequate evidence for metabolic benefits of OSA treatment in PCOS.

If you have PCOS and suspect sleep apnea (snoring, daytime sleepiness), get it treated to improve your energy and mood. However, do not expect treating sleep apnea to fix your blood sugar or cholesterol levels; focus on lifestyle changes for those metabolic goals.

Sleep disruption is associated with an increased risk of certain cancers (colorectal, breast, prostate) and all-cause mortality, particularly in men.

For shift workers and those with chronic sleep disorders, maintaining sleep continuity and circadian alignment is critical for long-term health. Evidence links these disruptions to higher risks of colorectal, breast, and prostate cancers, as well as increased mortality, particularly in men. Prioritizing sleep hygiene and treating sleep disorders may mitigate these risks.